These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26794911)

  • 41. Natural killer cells in antiviral defense: function and regulation by innate cytokines.
    Biron CA; Nguyen KB; Pien GC; Cousens LP; Salazar-Mather TP
    Annu Rev Immunol; 1999; 17():189-220. PubMed ID: 10358757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas.
    Cruz I; Meijer CJ; Walboomers JM; Snijders PJ; Van der Waal I
    Br J Cancer; 1999 Nov; 81(5):881-9. PubMed ID: 10555762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
    Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
    Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients.
    Pittari G; Fregni G; Roguet L; Garcia A; Vataire AL; Wittnebel S; Amsellem S; Chouaib S; Bourhis JH; Caignard A
    Bone Marrow Transplant; 2010 May; 45(5):862-71. PubMed ID: 19802033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.
    Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R
    Metabolism; 2014 Sep; 63(9):1188-97. PubMed ID: 24996265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
    J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis.
    Saito S; Murakoshi K; Kotake S; Kamatani N; Tomatsu T
    J Rheumatol; 2008 Oct; 35(10):1932-43. PubMed ID: 18785318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD25 (IL-2R) expression correlates with the target cell induced cytotoxic activity and cytokine secretion in human natural killer cells.
    Rudnicka K; Matusiak A; Chmiela M
    Acta Biochim Pol; 2015; 62(4):885-94. PubMed ID: 26645326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood Obesity and Cancer Risk in Adulthood.
    Weihe P; Spielmann J; Kielstein H; Henning-Klusmann J; Weihrauch-Blüher S
    Curr Obes Rep; 2020 Sep; 9(3):204-212. PubMed ID: 32519271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysregulation of Natural Killer Cells in Obesity.
    O'Shea D; Hogan AE
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31018563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NK cells vs. obesity: A tale of dysfunction & redemption.
    De Barra C; O'Shea D; Hogan AE
    Clin Immunol; 2023 Oct; 255():109744. PubMed ID: 37604354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.
    Parisi L; Bassani B; Tremolati M; Gini E; Farronato G; Bruno A
    J Immunol Res; 2017; 2017():4218254. PubMed ID: 28428965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination immune response in obese individuals.
    Votruba CD; Hayney MS
    J Am Pharm Assoc (2003); 2018; 58(1):121-122. PubMed ID: 29290340
    [No Abstract]   [Full Text] [Related]  

  • 59. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection and expansion of natural killer cells for NK cell-based immunotherapy.
    Becker PS; Suck G; Nowakowska P; Ullrich E; Seifried E; Bader P; Tonn T; Seidl C
    Cancer Immunol Immunother; 2016 Apr; 65(4):477-84. PubMed ID: 26810567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.